In memory of our Founder, Paul G. Allen
Paul G. Allen, 1953-2018
“Paul’s vision and insight have been an inspiration to me and to many others both here at the Institute that bears his name, and in the myriad of other areas that made up the fantastic universe of his interests. He will be sorely missed. We honor his legacy today, and every day into the long future of the Allen Institute, by carrying out our mission of tackling the hard problems in bioscience and making a significant difference in our respective fields.”
Allan Jones
President and CEO, Allen Institute
News
News
The genes that build our brains — and may drive neuropsychiatric diseases
December 17, 2018
Data from 60 human brains reveal how gene activity changes from before we are born to adulthood, pinpoint cells where psychiatric disorders may arise
Press Release
Announcing the Allen Institute for Immunology, a new research endeavor focused on human immune health and disease
December 12, 2018
Seeded by $125 million donation by the late Paul G. Allen, the Allen Institute for Immunology will study human immune health, cancer, and autoimmune diseases
Video
Meet the Allen Institute for Immunology’s research partners
December 12, 2018
The new Institute will work directly with samples and data from patients with immune-related diseases and healthy volunteers, thanks to a unique partnership with five leading research organizations.
Video
Allen Cell Methods: Techniques while working with Matrigel
December 10, 2018
To ensure researchers have success working with our human iPS cell lines in their lab, our Angel Nelson highlights helpful tips while working with Matrigel.
News
Two years of glowing cells for science
December 6, 2018
The Allen Cell Collection, debuted in 2016, houses cells labeling 27 different structures — and is now available for research use in both non-profit and for-profit communities
News
This human neuron is on a different wavelength than its mouse counterpart
December 5, 2018
Study uncovers subtle differences in how rodents and humans use the same kind of brain cell, could have implications for drug and disease research
